NovaBridge Biosciences NBP Growth Metrics (2019-2026)

NASDAQ NBP
$1.37 -0.05 (-3.86%)
As of: Oct 21, 2026 · 12:58 PM EDT
Reported Financials

NovaBridge Biosciences Quarterly Growth Metrics

Periods 19 quarters
Latest Jun 2026

NovaBridge Biosciences reported asset growth of 12.01% for the quarter ended Jun 2026. These growth metrics cover 19 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2019 Sep2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Growth Ratios
Assets Growth (1y) -28.00%290.42%228.37%-9.48%-21.74%-33.44%-35.01%-37.16%-47.59%-42.15%-18.56%19.22%22.49%12.01%
Assets Growth (3y) 36.52%32.99%18.64%-27.66%-35.64%-37.69%-34.78%-23.64%-21.81%
Assets Growth (5y) 1.25%-3.08%-6.55%-15.21%-23.14%-24.63%
Assets (QoQ) 118.30%53.41%-8.33%-8.60%-1.76%-1.07%34.20%-6.09%
Capital Expenditures Growth (1y)Capex Growth (1y) -54.71%
Capital Expenditures Growth (5y)Capex Growth (5y) -48.82%
Capital Expenditures (QoQ)Capex (QoQ) -30.74%3,700.00%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) -29.50%348.10%204.56%-24.21%-17.62%-16.53%-41.27%-34.72%-53.30%-77.34%8.85%187.50%208.56%15.26%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 33.78%41.53%13.80%-25.53%-39.09%-50.21%-33.16%-23.01%-16.33%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y) 5.46%-15.96%-5.61%-12.15%-22.00%-22.28%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 97.44%67.36%-47.80%-13.95%-21.48%208.61%37.88%-7.64%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -25.08%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y) -14.98%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) 119.84%99.87%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 600.37%-78.16%-33.31%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y) 18.60%-15.94%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -230.00%-893.69%
EBIT Growth (1y) -30.72%394.12%-42.24%-16.72%66.12%38.07%58.49%27.58%-445.21%
EBIT Growth (3y) 42.91%-31.68%
EBIT Growth (5y) 22.26%22.35%30.92%-20.34%
EBIT Margin Growth (3y) -78.93M
EBIT Margin (QoQ) 0.42M-78.59M
EBIT (QoQ) -8.35%343.78%11.75%-271.10%78.45%-101.58%27.58%-7.73%60.62%-35.09%-26.36%-710.99%
EBT Growth (1y) 105.03%421.52%67.55%-149.25%70.62%66.56%38.45%66.68%-571.87%
EBT Growth (3y) -88.12%-30.69%
EBT Growth (5y) 10.21%26.18%-42.46%-19.71%
EBT Margin Growth (3y) -73.83M
EBT Margin (QoQ) 1.47M-73.56M
EBT (QoQ) -40.89%8,907.73%70.17%-348.97%74.48%5.06%-129.15%47.08%70.95%-74.73%-24.06%-967.05%
EPS (Basic) Growth (1y) 140.53%38.91%83.31%80.21%-122.46%65.84%-140.69%
EPS (Basic) Growth (3y) -31.94%
EPS (Basic) Growth (5y) -16.21%
EPS (Basic) (QoQ) 45.90%-98.58%75.50%253.99%-181.55%45.75%70.95%-74.73%-24.06%-282.25%
EPS (Diluted) Growth (1y) 140.53%38.91%83.31%80.21%-122.46%65.84%-140.69%
EPS (Diluted) Growth (3y) -32.91%
EPS (Diluted) Growth (5y) -16.43%
EPS (Diluted) (QoQ) 45.90%-98.58%75.50%253.99%-181.55%45.75%70.95%-74.73%-24.06%-282.25%
Free Cash Flow Growth (1y)FCF Growth (1y) 581.76%-78.16%-32.85%
Free Cash Flow Growth (5y)FCF Growth (5y) 19.11%35.69%-15.95%
Free Cash Flow (QoQ)FCF (QoQ) 21,707.69%-230.47%-893.69%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -196.88%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -813.50%
Net Cash Flow Growth (1y)NCF Growth (1y) 8,133.17%185.46%-59.33%
Net Cash Flow Growth (5y)NCF Growth (5y) -25.18%-23.52%-15.56%
Net Cash Flow (QoQ)NCF (QoQ) 20.86%84.90%-128.15%
Net Income Growth (1y) 105.03%417.79%140.79%38.38%84.03%79.42%-107.39%66.68%-571.87%
Net Income Growth (3y) -175.19%-34.48%
Net Income Growth (5y) 10.21%26.18%-42.46%-19.76%
Net Income (QoQ) -40.89%8,803.18%45.90%-104.17%77.48%263.97%-181.73%47.08%70.98%41.15%-268.68%-967.05%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) 105.03%390.26%140.88%38.38%83.72%80.69%-121.91%66.68%-183.91%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) -175.19%-34.33%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y) 10.21%27.50%-42.46%-17.04%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -54.25%8,803.18%45.90%-100.29%75.50%253.99%-181.55%47.08%70.95%-74.73%-24.06%-350.89%
Net Margin Growth (3y) -133.23M
Net Margin (QoQ) 2.81M-132.16M
Operating Income Growth (1y)Op. Inc Growth (1y) -30.72%394.12%-42.24%-16.72%66.12%38.07%58.49%27.58%-445.21%
Operating Income Growth (3y)Op. Inc Growth (3y) 42.91%-31.68%
Operating Income Growth (5y)Op. Inc Growth (5y) 22.26%22.35%30.92%-20.34%
Operating Income (QoQ)Op. Inc (QoQ) -8.35%343.78%11.75%-271.10%78.45%-101.58%27.58%-7.73%60.62%-35.09%-26.36%-710.99%
Operating Margin Growth (3y) -78.93M
Operating Margin (QoQ) 0.42M-78.59M
Profit After Tax Growth (1y)PAT Growth (1y) 105.03%417.79%67.55%-149.25%70.62%66.56%38.45%66.68%-571.87%
Profit After Tax Growth (3y)PAT Growth (3y) -88.12%-30.74%
Profit After Tax Growth (5y)PAT Growth (5y) 10.21%26.18%-42.46%-19.76%
Profit After Tax (QoQ)PAT (QoQ) -40.89%8,803.18%70.17%-348.97%74.48%5.06%-129.15%47.08%70.95%-74.73%-24.06%-967.05%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 7.02%-9.98%-8.30%85.16%164.12%21.79%-20.55%-41.20%-97.19%-96.09%-15.69%-16.67%-30.35%636.05%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) 21.28%26.62%24.38%9.86%-61.06%-69.63%-73.39%-74.79%-44.11%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y) 5.02%-45.82%-46.07%-47.76%-48.53%-18.20%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 5.73%-2.77%-8.82%8.06%-6.47%-8.51%-9.88%-9.68%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.00M0.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y) 0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.00M520.000.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.00M0.00M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y) 0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 948.0027.00470.00366.000.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y) 0.00M0.00M
Return on Equity [ROE] Growth (5y)ROE Growth (5y) 0.00M
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.00M551.000.00M0.00M0.00M
Return on Sales [ROS] Growth (3y)ROS Growth (3y) -78.93M
Return on Sales [ROS] (QoQ)ROS (QoQ) 0.42M-78.59M
Revenue Growth (3y) -97.21%
Revenue (QoQ) 98.11%-98.41%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 1,420,711.99%509.27%163.35%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y) 302.46%-42.67%-27.84%
Share-based Compensation (QoQ)Stock Comp. (QoQ) -14.29%520.79%170.76%
Total Debt Growth (1y) -38.47%54.90%
Total Debt Growth (3y) -27.55%
Total Debt Growth (5y) -18.37%

NovaBridge Biosciences Growth Metrics API

Pull NovaBridge Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NBP&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY